SELLAS Life Sciences Group Inc. announced that the first patient has been enrolled in the clinical trial of its innovative drug SLS009 for first-line treatment of newly diagnosed acute myeloid leukemia (AML).

SELLAS Life Sciences Group Inc. announced that the first patient has been enrolled in the clinical trial of its innovative drug SLS009 for first-line treatment of newly diagnosed acute myeloid leukemia (AML).

老虎证券2026/03/12 12:59

Show original

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

This development marks the official entry of this therapy into the clinical validation stage, bringing new hope for treatment to AML patients.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Malaysia’s EPF raised its direct stake in Pavilion Real Estate Investment Trust via an acquisition of 1,449,500 units on Oct. 5, 2026. Holding rose to 522,094,947 units, equal to 13.28% voting interest. Notice was dated Oct. 6, 2026. The issuer received it on Oct. 8, 2026. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Pavilion Real Estate Investment Trust published the original content used to generate this news brief via Bursa Malaysia (KLSE) (Ref. ID: 3713220) on October 08, 2026, and is solely responsible for the information contained therein.

Bitget•2026/10/08 09:33